SEC Form 4 · accession 0001127602-17-024715
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Kuntz
Officer — SrVP & Chief Scien, Clin, Reg
Period of report
Jul 31, 2017
Accepted (ET)
Aug 2, 2017 · 3:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jul 31, 2017 | A | 10,322 | $0.00 | A | 113,945 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $83.97 | Jul 31, 2017 | A | 41,285 | A | Jul 31, 2018 | Jul 31, 2027 | Ordinary Shares | 41,285 | 41,285 | D |
| Stock Option (Right to Buy)F2 | $83.97 | Jul 31, 2017 | A | 1,191 | A | Jul 31, 2018 | Jul 31, 2027 | Ordinary Shares | 1,191 | 1,191 | D |
Explanation of responses
- F1The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2020 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee.
- F2These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.